The U.S. House of Representatives has passed the bipartisan BIOSECURE Act, targeting Chinese biotech firms such as WuXi AppTec and WuXi Biologics as national security risks. The legislation restricts American companies from partnering with these firms, potentially disrupting the drug supply chain. Bipartisan SupportThe bill passed with a strong majority of 306-81, garnering support from